Surgimatix is an early-stage medical device company pioneering the 1st laparoscopic device that delivers suture-like fixation in seconds for minimally invasive procedures

Perspectives

"I’ve had a long-standing interest in research and innovation that directly address clinical needs that my colleagues and I face in taking care of patients. With Surgimatix, we assembled a talented team of clinicians, engineers, and medical device specialists to develop these solutions. We’re excited about the broad applicability of our first-of-its-kind surgical fixation platform and look forward to carrying it into the clinical arena. We’ve brought on a multi-disciplinary management team of industry veterans who are accelerating our drive toward commercialization and development of pipeline applications, allowing me to further focus on clinical work and teaching."

Jafar Hasan, MD, MBA, FACS, Co-Founder, Surgimatix.

"Our approach at Surgimatix is to imagine a much better way to perform laparoscopic soft tissue fixation. We look for a significant unmet clinical need with a large market opportunity. Adoption of new medical device products requires a deep understanding of product/market fit and an experienced cross-functional team of researchers & clinical advisors, engineers, project management, regulatory, finance, and commercial experts who are excited by the possibilities and are committed to the work. We execute with focus and discipline to advance the practice of medicine through our products for surgeons, health systems, and patients, and to generate attractive returns for shareholders and team members."

Jane Kiernan, CEO, Surgimatix.

“As a Urogynecologist, I am truly impressed by this groundbreaking device for suturing that reduces the reliance on the use of multiple needles and optimizes surgical efficiency. Innovations like this has the potential to revolutionize our surgical procedure of sacralcolpopexy, enhance patient outcomes, and significantly reduce procedural time. The idea of minimizing the use of needles not only aligns with advancements in safety and precision but also addresses critical aspects like reducing patient trauma and enhancing recovery times. The Surgimatrix device is a testament to how cutting-edge technology can solve practical challenges that we face in the field of reconstructive pelvic surgery.”

Andrea Pezzella, MD, URPS, FACOG

"The field of reconstructive pelvic surgery requires a great deal of laparoscopic suturing and knot tying. Not only does this require advanced laparoscopic skills associated with a long learning curve, but it is time consuming and potentially hazardous. Whenever a needle is grasped by a needle driver inside the body, there is the potential for inadvertent injury to adjacent organs and blood vessels. The Surgimatix device should not only significantly reduce the time required to perform tissue approximation and mesh attachment but will also reduce the possibility of injuries by eliminating the risk associated with exposed needles in the abdomen."

Peter Rosenblatt, MD Obstetrics and Gynecology , Urogynecology at Mount Auburn Hospital, Boston, MA

“The design of handles/touch points for surgical tools and instruments we use have changed very little in 30+ years. The emerging data about how ergonomics impacts much of what a surgeon does will change how we work and how products are developed. This is an extremely important consideration as the national and global demographics of our profession change with more women surgeons.”

Ian S. Soriano, MD is an Associate Professor of Clinical Surgery at the University of California San Francisco School of Medicine and Surgeon Champion, ACS-NSQIP at the UCSF Helen Diller Medical Center; Chair, Education Committee of the Society of Surgical Ergonomics.

"My primary considerations when utilizing a new surgical device or tool include: Is this better for patients? Does this facilitate a new procedure? Does this reduce operative time and operative pain?"

Eric M Pauli, MD FACS FASGE is the David L Nahrwold Professor of Surgery and the Chief of the Division of Minimally Invasive and Bariatric Surgery at the Penn State Health Milton S Hershey Medical Center in Hershey, Pennsylvania, USA. Currently serves as a board member of The Society of American Gastrointestinal Endoscopy and The American Hernia Society.

“ I welcome innovation in the space. Fixation is important. We haven’t found the ideal technique and/or products. We have a long way to go as there is an opportunity to learn about better ways to deliver fixation of mesh in minimally invasive surgery.”

William Hope, M.D. FACS is Associate Professor of Surgery at the University of North Carolina at Chapel Hill. Past President of the Americas Hernia Society and is a board member of the Americas Hernia Society Quality Collaborative.

“With so many surgeons requiring robotics as their only choice to accomplish suture-based fixation to the abdominal wall, wait times and access have become an issue that has the potential to be solved with the use of absorbable based suture fixation in a device that doesn’t require a robot.”

Christopher Schneider, MD, FACS, is a general surgery specialist in Dayton, OH. Dr. Schneider is Assistant Professor of Surgery at Wright State University Boonshoft College of Medicine in the Department of Minimally Invasive and Robotic Surgery.

"Today, the term Innovation is overused and overapplied. Actual Innovation occurs when an invention changes how people conduct their lives to achieve astonishing results. The Surgimatix fixation technology exemplifies this with a novel approach to new product innovation. By returning physicians to the essentials of successful tissue healing, namely volumetric suture fixation, true innovation has been realized."

John Crombie, Medical Device Inventor & Entrepreneur, and Medical Device Industry Veteran, J&J.

Timeline



2017

Received First Patent

To date, 43 active and issued patents and additional applications pending.

2020/2021

Strengthened Clinical and Industry Experience, Obtained FDA 510(k) Clearance

Indication for Use: “The Surgimatix Absorbable Fixation System is indicated for the approximation of soft tissue and fixation of surgical mesh to tissues during open or laparoscopic surgical procedures, such as hernia repair.”



2022

Expanded Team & Developed Business Plan

Hired CEO, VP Operations & Engineering, and Established Board of Directors. Engaged Expert Capabilities – Engineering [relevant medical device experience] and Scientific & Clinical Advisory Board. Commenced Series A financing.



2023/2025

Initiate Pre-commercialization Activities

Closed Series A financing, $6M, to advance value creating milestones: Optimize aproxim8™ device for manufacturability and ergonomics in preparation for Limited Release- First in Human Use. Confirm product/market fit for target use case/procedure. Select and engage contract manufacturing partners.



2025/2026

Launch aproxim8™

Raise Series A Extension. Expand capabilities and experience of team, cultivate relationships with surgeons, deliver optimized aproxim8™, execute Limited Release – First Human Use, and generate data to demonstrate benefit.

Team

Jane Kiernan

CEO & Interim CFO

Steve Ek

Chief Technology Officer

Michael Shoup

VP of Operations & QA/RA

Chris Seguin

Senior Director of Engineering

Adam Saban

Engineering

John Dichiara

Regulatory

Tom Smestad

Quality

Gary Kobylewski

Model Maker & Surgical Technologist

Surgeon Advisors

Jafar Hasan, MD

Co-Founder

Karen Noblett

MD, MBA

Eric Pauli

MD, FACS, FASGE

Chris Schneider

MD, FACS

Andrea Pezzella

MD, URPS, FACOG

Peter Rosenblatt

Business Advisors

Surgimatix has engaged an impressive group of highly experienced, networked medical device leaders with a track record of creating significant value through their business acumen, financial, and operational experience. These individuals are motivated to improve the delivery of healthcare, help early-stage companies succeed, and generate attractive returns.

Join Our Team

No Open Positions At The Moment

Surgeon Advisors [Consultants] are paid by Surgimatix.